Clinical trial
A Prospective,Multicenter, Single-arm Clinical Trial to Evaluate Safety and Efficacy of TaurusOne® Transcatheter Aortic Valve Replacement System With Retrievable Delivery Catheter System
NCT04744857 is registered in ClinicalTrials.gov with Peijia Medical Technology (Suzhou) Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective,Multicenter, Single-arm Clinical Trial to Evaluate Safety and Efficacy of TaurusOne® Transcatheter Aortic Valve Replacement System With Retrievable Delivery Catheter System
- Lead sponsor
- Peijia Medical Technology (Suzhou) Co., Ltd.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 13, 2019
- Completion date
- October 16, 2020
- Enrollment
- 85 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
aortic stenosis